ATE349702T1 - Nachweis und quantifizierung von cripto-1 - Google Patents

Nachweis und quantifizierung von cripto-1

Info

Publication number
ATE349702T1
ATE349702T1 AT02703238T AT02703238T ATE349702T1 AT E349702 T1 ATE349702 T1 AT E349702T1 AT 02703238 T AT02703238 T AT 02703238T AT 02703238 T AT02703238 T AT 02703238T AT E349702 T1 ATE349702 T1 AT E349702T1
Authority
AT
Austria
Prior art keywords
cripto
quantification
detection
present
serum
Prior art date
Application number
AT02703238T
Other languages
English (en)
Inventor
Caterina Bianco
David Salomon
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE349702T1 publication Critical patent/ATE349702T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/485Epidermal growth factor [EGF] (urogastrone)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Sub-Exchange Stations And Push- Button Telephones (AREA)
  • Glass Compositions (AREA)
  • Testing Of Coins (AREA)
AT02703238T 2001-01-26 2002-01-23 Nachweis und quantifizierung von cripto-1 ATE349702T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26464301P 2001-01-26 2001-01-26

Publications (1)

Publication Number Publication Date
ATE349702T1 true ATE349702T1 (de) 2007-01-15

Family

ID=23006978

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02703238T ATE349702T1 (de) 2001-01-26 2002-01-23 Nachweis und quantifizierung von cripto-1

Country Status (9)

Country Link
US (1) US7078176B2 (de)
EP (1) EP1370869B1 (de)
JP (1) JP3821779B2 (de)
AT (1) ATE349702T1 (de)
AU (1) AU2002236871B2 (de)
CA (1) CA2434694C (de)
DE (1) DE60217079T2 (de)
ES (1) ES2278899T3 (de)
WO (1) WO2002059620A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020010928A1 (en) * 2000-04-24 2002-01-24 Ranjit Sahota Method and system for integrating internet advertising with television commercials
PT1390389E (pt) 2001-04-26 2009-04-03 Biogen Idec Inc Anticorpos que bloqueiam o cripto e as utilizações dos mesmos
US7582299B2 (en) 2001-04-26 2009-09-01 Biogen Idec Ma Inc. Cripto-specific antibodies
AU2003301619A1 (en) * 2002-10-23 2004-05-13 Exelixis, Inc. MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE
CA2502685A1 (en) * 2002-10-23 2004-05-06 Exelixis, Inc. Cdkl1 as modifier of branching morphogenesis and methods of use
US20070122813A1 (en) * 2003-10-03 2007-05-31 David Salomon Use of cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof
ES2408704T3 (es) 2005-01-05 2013-06-21 Biogen Idec Ma Inc. Moléculas de unión a Cripto
JP2011522224A (ja) * 2008-04-21 2011-07-28 メルク・シャープ・エンド・ドーム・コーポレイション 膵ベータ細胞質量生物マーカー
US20100135904A1 (en) * 2008-11-07 2010-06-03 Research Development Foundation Compositions and methods for the inhibition of cripto / grp78 complex formation and signaling

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US579616A (en) * 1897-03-30 Rod-packing for air-brakes
US5256643A (en) 1990-05-29 1993-10-26 The Government Of The United States Human cripto protein
US5264557A (en) 1991-08-23 1993-11-23 The United States Of America As Represented By The Department Of Health And Human Services Polypeptide of a human cripto-related gene, CR-3
US5981215A (en) * 1995-06-06 1999-11-09 Human Genome Sciences, Inc. Human criptin growth factor
US5968839A (en) * 1996-05-13 1999-10-19 Metrika, Inc. Method and device producing a predetermined distribution of detectable change in assays
US6777198B2 (en) * 2000-10-11 2004-08-17 Pharmacia Diagnostics Ab Assay method and kit therefor

Also Published As

Publication number Publication date
WO2002059620A3 (en) 2003-03-27
WO2002059620A2 (en) 2002-08-01
JP2005504262A (ja) 2005-02-10
AU2002236871C1 (en) 2002-08-06
CA2434694A1 (en) 2002-08-01
JP3821779B2 (ja) 2006-09-13
AU2002236871B2 (en) 2006-09-28
US20040077025A1 (en) 2004-04-22
EP1370869A2 (de) 2003-12-17
EP1370869B1 (de) 2006-12-27
CA2434694C (en) 2012-09-18
ES2278899T3 (es) 2007-08-16
DE60217079D1 (de) 2007-02-08
DE60217079T2 (de) 2007-10-25
US7078176B2 (en) 2006-07-18

Similar Documents

Publication Publication Date Title
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
WO2003000853A3 (en) Protein aggregation assays and uses thereof
WO2005012574A3 (en) Biological bar-code
MX340077B (es) Sistemas de fluidos de punto de cuidado y usos de los mismos.
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
WO2003064993A3 (en) Methods and materials for detecting genetic material
NO20041160L (no) Bio-avlesningsplattform for pavisning og kvantitering av biologiske molekyler
ATE256131T1 (de) Calanolide zur hemmung von btk
WO2005042770A3 (en) Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
DK1636561T3 (da) Kombinatorisk proteinbiblioteksscreening ved hjælp af periplasmatisk ekspression
AU2002259117A1 (en) Systems and methods for detection of analytes in biological fluids
ATE349702T1 (de) Nachweis und quantifizierung von cripto-1
WO2004016160A3 (en) Redox polymer nanoparticles
WO2009082445A3 (en) Novel devices for the detection of the presence and/or activity of proteases in biological samples
WO2005085849A3 (en) Biohazard identification by fluorescent immunoassay and single molecule detection
SE0000675D0 (sv) Monoclonal antibodies
EP1482433A3 (de) Automatisierung von Proteindesign zum Entwerfen von Proteinbibliotheken
BR0014626A (pt) Análise de leptina
IL151264A0 (en) Devices for analyte concentration determination and methods of using the same
WO2003027251A3 (en) Novel molecules of the pyrin domain protein family and uses thereof
EP1265073A3 (de) Verfahren zum Nachweis von der Plasmakonzentration von freien Arzneimitteln
AU2002340881A1 (en) Concentration of protein and/or peptides samples
MXPA02005109A (es) Metodo para calibrar un analizador de muestras.
WO2004094989A3 (en) Methods of host cell protein analysis
WO2002004656A3 (de) Biosonden und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties